42 related articles for article (PubMed ID: 15036654)
21. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
[TBL] [Abstract][Full Text] [Related]
22. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells.
Kim SG; Kim HH; Kim HK; Kim CH; Chun HS; Kanai Y; Endou H; Kim DK
Anticancer Res; 2006; 26(3A):1989-96. PubMed ID: 16827134
[TBL] [Abstract][Full Text] [Related]
23. The Regulation and Function of the L-Type Amino Acid Transporter 1 (LAT1) in Cancer.
Salisbury TB; Arthur S
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103560
[TBL] [Abstract][Full Text] [Related]
24. [Amino acid transporter molecule as a drug target].
Endou H; Kanai Y
Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():11P-16P. PubMed ID: 10629848
[TBL] [Abstract][Full Text] [Related]
25. Thyroid hormone transport across L-type amino acid transporters: What can molecular modelling tell us?
Krause G; Hinz KM
Mol Cell Endocrinol; 2017 Dec; 458():68-75. PubMed ID: 28341457
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a new amino acid transport system in human epidermal Langerhans cells: the L-dopa influx/efflux cycle.
Bendsöe N
Ups J Med Sci; 2003; 108(3):161-92. PubMed ID: 15000456
[TBL] [Abstract][Full Text] [Related]
27. The L-Type Amino Acid Transporter LAT1-An Emerging Target in Cancer.
Häfliger P; Charles RP
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100853
[TBL] [Abstract][Full Text] [Related]
28. The role of CD98 in astrocytic neoplasms.
Nawashiro H; Otani N; Shinomiya N; Fukui S; Nomura N; Yano A; Shima K; Matsuo H; Kanai Y
Hum Cell; 2002 Mar; 15(1):25-31. PubMed ID: 12126061
[TBL] [Abstract][Full Text] [Related]
29. Targeting L-type amino acid transporter 1 for anticancer therapy: clinical impact from diagnostics to therapeutics.
Jin SE; Jin HE; Hong SS
Expert Opin Ther Targets; 2015; 19(10):1319-37. PubMed ID: 25968633
[TBL] [Abstract][Full Text] [Related]
30. L-type amino acid transporter 1 as a target for inflammatory disease and cancer immunotherapy.
Hayashi K; Anzai N
J Pharmacol Sci; 2022 Jan; 148(1):31-40. PubMed ID: 34924127
[TBL] [Abstract][Full Text] [Related]
31. The role of L-type amino acid transporter 1 in human tumors.
Zhao Y; Wang L; Pan J
Intractable Rare Dis Res; 2015 Nov; 4(4):165-9. PubMed ID: 26668776
[TBL] [Abstract][Full Text] [Related]
32. L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.
Wang Q; Holst J
Am J Cancer Res; 2015; 5(4):1281-94. PubMed ID: 26101697
[TBL] [Abstract][Full Text] [Related]
33. Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment.
Hayashi K; Anzai N
World J Gastrointest Oncol; 2017 Jan; 9(1):21-29. PubMed ID: 28144396
[TBL] [Abstract][Full Text] [Related]
34. Expression and functional characterization of the system L amino acid transporter in KB human oral epidermoid carcinoma cells.
Yoon JH; Kim YB; Kim MS; Park JC; Kook JK; Jung HM; Kim SG; Yoo H; Ko YM; Lee SH; Kim BY; Chun HS; Kanai Y; Endou H; Kim DK
Cancer Lett; 2004 Mar; 205(2):215-26. PubMed ID: 15036654
[TBL] [Abstract][Full Text] [Related]
35. System L: heteromeric exchangers of large, neutral amino acids involved in directional transport.
Verrey F
Pflugers Arch; 2003 Feb; 445(5):529-33. PubMed ID: 12634921
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2.
del Amo EM; Urtti A; Yliperttula M
Eur J Pharm Sci; 2008 Oct; 35(3):161-74. PubMed ID: 18656534
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]